BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9742282)

  • 1. Changes in nasal reactivity in patients with rhinitis medicamentosa after treatment with fluticasone propionate and placebo nasal spray.
    Graf PM; Hallén H
    ORL J Otorhinolaryngol Relat Spec; 1998; 60(6):334-8. PubMed ID: 9742282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluticasone propionate nasal spray is more effective and has a faster onset of action than placebo in treatment of rhinitis medicamentosa.
    Hallén H; Enerdal J; Graf P
    Clin Exp Allergy; 1997 May; 27(5):552-8. PubMed ID: 9179430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of rhinitis medicamentosa with fluticasone propionate--an experimental study.
    Elwany S; Abdel-Salaam S
    Eur Arch Otorhinolaryngol; 2001 Mar; 258(3):116-9. PubMed ID: 11374251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
    Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
    J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relief of sinus pain and pressure with fluticasone propionate aqueous nasal spray: a placebo-controlled trial in patients with allergic rhinitis.
    Ratner PH; Howland WC; Jacobs RL; Reed KD; Goode-Sellers ST; Prillaman BA; Philpot EE; Cook CK
    Allergy Asthma Proc; 2002; 23(4):259-63. PubMed ID: 12221896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment.
    Graf P; Hallén H
    ORL J Otorhinolaryngol Relat Spec; 1997; 59(1):39-44. PubMed ID: 9104748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intranasal fluticasone proprionate on the immediate and late allergic reaction and nasal hyperreactivity in patients with a house dust mite allergy.
    de Graaf-in't Veld C; Garrelds IM; Jansen AP; Van Toorenenbergen AW; Mulder PG; Meeuwis J; Gerth van Wijk R
    Clin Exp Allergy; 1995 Oct; 25(10):966-73. PubMed ID: 8556568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of topical fluticasone propionate on intranasal histamine challenge in subjects with perennial allergic rhinitis.
    Birchall MA; Henderson JC; Studham JM; Phillips I; Pride NB; Fuller RW
    Clin Otolaryngol Allied Sci; 1995 Jun; 20(3):204-10. PubMed ID: 7554327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis.
    Weido AJ; Reece LM; Alam R; Cook CK; Sim TC
    Ann Allergy Asthma Immunol; 1996 Nov; 77(5):407-15. PubMed ID: 8933780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge.
    Rak S; Jacobson MR; Sudderick RM; Masuyama K; Juliusson S; Kay AB; Hamid Q; Löwhagen O; Durham SR
    Clin Exp Allergy; 1994 Oct; 24(10):930-9. PubMed ID: 7842362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of short-term treatment with fluticasone propionate nasal spray on the response to nasal allergen challenge.
    Scadding GK; Darby YC; Austin CE
    Br J Clin Pharmacol; 1994 Nov; 38(5):447-51. PubMed ID: 7893587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One year follow-up of patients with rhinitis medicamentosa after vasoconstrictor withdrawal.
    Graf PM; Hallén H
    Am J Rhinol; 1997; 11(1):67-72. PubMed ID: 9065350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onset of therapeutic effect of fluticasone propionate aqueous nasal spray.
    Meltzer EO; Rickard KA; Westlund RE; Cook CK
    Ann Allergy Asthma Immunol; 2001 Mar; 86(3):286-91. PubMed ID: 11289326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluticasone propionate aqueous nasal spray in pregnancy rhinitis.
    Ellegård EK; Hellgren M; Karlsson NG
    Clin Otolaryngol Allied Sci; 2001 Oct; 26(5):394-400. PubMed ID: 11678947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide metabolites in nasal lavage fluid of patients with house dust mite allergy.
    Garrelds IM; van Amsterdam JG; de Graaf-in't Veld C; Gerth van Wijk R; Zijlstra FJ
    Thorax; 1995 Mar; 50(3):275-9. PubMed ID: 7660342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once daily intranasal fluticasone propionate is effective for perennial allergic rhinitis.
    Banov CH; Woehler TR; LaForce CF; Pearlman DS; Blumenthal MN; Morgan WF; Frazer H; Southern DL; Gold B; Field E
    Ann Allergy; 1994 Sep; 73(3):240-6. PubMed ID: 8092559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: a randomized, multicenter, double-blind, single-dose, crossover study.
    Meltzer EO; Stahlman JE; Leflein J; Meltzer S; Lim J; Dalal AA; Prillaman BA; Philpot EE
    Clin Ther; 2008 Feb; 30(2):271-9. PubMed ID: 18343265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal fluticasone propionate for chronic eosinophilic rhinitis in patients with aspirin-induced asthma.
    Mastalerz L; Milewski M; Duplaga M; Nizankowska E; Szczeklik A
    Allergy; 1997 Sep; 52(9):895-900. PubMed ID: 9298173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluticasone propionate: an effective alternative treatment for seasonal allergic rhinitis in adults and adolescents.
    LaForce CF; Dockhorn RJ; Findlay SR; Meltzer EO; Nathan RA; Stricker W; Weakley S; Field EA; Rogenes PR
    J Fam Pract; 1994 Feb; 38(2):145-52. PubMed ID: 8308505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal steroids improve regulation of nasal patency in asthma and mild rhinitis: a randomised, cross-over trial.
    Rimmer J; Greenwood A; Bartlett D; Hellgren J
    Eur Arch Otorhinolaryngol; 2012 Apr; 269(4):1133-8. PubMed ID: 22033572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.